Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma
Clinical trial NCT01465464 · TERMINATED
Trial details
- NCT number
- NCT01465464
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2014-06-01
- Enrollment
- 888
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.